2-[4-(8-Bromo-2-oxo-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)phenyl]-2-methylpropionitrile, 98%, 50mg

2-(4-Fluorophenyl)ethyl Bromide>95.0%(GC)5g

(R)-tert-Butyl 1,4-oxazepan-6-ylcarbamate, 97%, 100mg

2-(4-(PIPERIDIN-4-YLOXY)PHENYL)ACETAMIDE, 95.0%, 1g

(5-Methoxy-[1,1'-biphenyl]-3-yl)boronic acid, 95%, 1g

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate, 98%, 250mg

tert-Butyl N-[(3S,4S)-4-fluoropiperidin-3-yl]carbamate, 97%, 1g

Plaques de support classiques, 160 mm, 250 mm, 1 pièce

Methyl 2-amino-4-chloro-5-iodobenzoate, 95.0%, 25g

(4S,5R)-2-(6-Benzhydrylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 97%, 1g

4-Chlorobenzyl bromide, 97.0%, 5g

1-(2-methoxypyridin-3-yl)methanamine; oxalic acid, 95.0%, 250mg

2-Chloro-4-methoxy-benzonitrile, 97.0%, 25g